Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Post-PE Syndrome and Transcatheter Therapy
Author(s): Belén Biscotti Rodil , Juan Duarte Torres , Irene Martín de Miguel , et al Added: 1 month ago

Heart Failure
Percutaneous Closure of an Aortopulmonary Window in an Adult Woman
Author(s): Felipe Eduardo Macías Prado , Jhon Mario German Gaibor , Rafel Ernesto Portaluppi Cervantes , et al Added: 2 months ago

Imaging & Diagnostics

Intervention
ACC 2025 Late-Breaking and Featured Science Collection
Author(s): Rajesh Kharbanda , Harriette Van Spall Added: 11 months ago
Keep up-to-date with our video collection on the American College of Cardiology's 74th annual congress, covering late-breaking science, featured science and clinical horizon sessions. Don't miss the preview and wrap-up of the congress in our View From the Thoraxcenter series, concise Expert Interviews with select faculty offering take-home messages for practice, and our Highlights summarising the… View more

Heart Failure

Intervention
AHA 2023 Late-Breaking Science Lineup Revealed
Added: 2 years ago Source:  AHA
AUTHOR: Jordan RanceThe American Heart Association has announced eight late-breaking science sessions to be presented in Philadelphia from November 10th to November 13th. AHA is focussed on innovation in cardiovascular disease for scientists, clinicians, researchers and other healthcare professionals.Among the event’s highlights are eight late-breaking trial sessions, as listed below.Watch our… View more
Jiguang Wang
Job title: Director
Dr Wang is Director of the Shanghai Institute of Hypertension, Director of the Department of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. At present, he is coordinating several multicentre randomised clinical trials and population- and patient-cohort studies in China. He has published 587 full-length articles on hypertension in the international… View more
Markus Schlaich
Job title: Renal Physician and Hypertension Specialist
Prof Markus Schlaich (Royal Perth Hospital and University of Western Australia, Perth, AU) is a Renal Physician and an ESH accredited Hypertension Specialist with a strong background in clinical research. His main scientific interests focus on pathophysiologic aspects of hypertension. Prof Schlaich has a specific interest in treatment modalities targeting the sympathetic nervous system and has… View more
A New Momentum for Renal Denervation: 2023 ESH Guidelines
Author(s): Joost Daemen , Added: 2 years ago
In light of the recent ESC clinical consensus statement on Renal Denervation (RDN), a significant development has occurred in the management of hypertension. The European Society of Hypertension (ESH) has officially endorsed Renal Denervation as a recommended treatment for hypertension. This marks a pivotal moment in the field of hypertension management.This broadcast features a compelling… View more

Intervention

Prevention & Chronic Conditions
Alta Schutte
Job title: Principal Theme Lead of Cardiac, Vascular and Metabolic Medicine
Prof Alta Schutte is Principal Theme Lead of Cardiac, Vascular and Metabolic Medicine in the Faculty of Medicine at the University of New South Wales, Sydney, Australia; with a joint appointment as Professorial Fellow at the George Institute for Global Health. She has extensive experience in working in the field of hypertension and cardiovascular disease with approx. 450 publications in the field… View more
Giuseppe Mancia
Job title: Chairman of the Department of Clinical Medicine and Prevention
Giuseppe Mancia is an Italian physician and scientist internationally recognized for his lifelong contributions to cardiovascular medicine and hypertension research. He has spent the majority of his academic and clinical career in Milan and Monza, Italy, where he has played a central role in shaping modern hypertension research, education, and clinical practice across Europe and worldwide… View more
Ian Wilkinson
Job title: President of the British and Irish Hypertension Society and Professor of Therapeutics
Prof Ian Wilkinson is President of the British and Irish Hypertension Society and leads the Division of Experimental Medicine and Immunotherapeutics at the University of Cambridge. He has over 25 years of research experience in hypertension, leading national trials including AIMHY Trial and POPPY Study. He directs the Cambridge Clinical Trials Unit and provides specialist hypertension services,… View more